The U.S. Food and Drug Administration this week approved Truvada PrEP for adolescents, making the once-daily HIV prevention pill more widely available to a group with a disproportionately high risk of infection.
In advance of Hepatitis Testing Day Saturday, May 19, public health officials and advocates will hold a rally Friday to raise awareness about hepatitis B and C and encourage people to get tested.
It took the voices of student activists to motivate San Francisco State University to once again offer free HIV and sexually transmitted infection testing to LGBT students, while heterosexual students have had that service for years.
Lyon-Martin Health Services is now under new leadership after the resignation of Dr. Dawn Harbatkin, who served as executive director for four years and medical director for eight.
The San Francisco Health Commission unanimously backed a resolution supporting supervised injection services at its February 6 meeting, putting the city one step closer to opening the first safe injection facility in the United States.
A gay man with years of experience fighting HIV/AIDS has become the chief medical officer for Alameda Alliance for Health, a managed care health plan that works to provide affordable services in Alameda County.
The U.S. FDA announced on Monday the approval of Truvada, a once-daily combination made by Gilead Sciences, for pre-exposure prophylaxis — better known as PrEP — to prevent sexual transmission of HIV
